ZIG
VRTX icon

Zullo Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Zullo Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Sell
660
-1
-0.2% -$443 0.11% 121
2026
Q1 		$295K Buy
661
+2
+0.3% +$933 0.11% 124
2025
Q4 		$299K Sell
659
-20
-3% -$8.62K 0.11% 118
2025
Q3 		$266K Buy
679
+2
+0.3% +$836 0.1% 131
2025
Q2 		$301K Sell
677
-126
-16% -$58.1K 0.12% 122
2025
Q1 		$389K Buy
803
+1
+0.1% +$466 0.17% 100
2024
Q4 		$323K Buy
802
+50
+7% +$23.2K 0.13% 113
2024
Q3 		$350K Sell
752
-28
-4% -$13.4K 0.15% 107
2024
Q2 		$366K Sell
780
-14
-2% -$6.08K 0.16% 105
2024
Q1 		$332K Buy
794
+10
+1% +$4.23K 0.16% 109
2023
Q4 		$319K Buy
784
+1
+0.1% +$369 0.16% 110
2023
Q3 		$272K Hold
783
– – 0.16% 112
2023
Q2 		$276K Hold
783
– – 0.16% 113
2023
Q1 		$247K Sell
783
-35
-4% -$10.5K 0.15% 117
2022
Q4 		$236K Sell
818
-53
-6% -$16.2K 0.14% 117
2022
Q3 		$252K Sell
871
-66
-7% -$19K 0.16% 110
2022
Q2 		$264K Sell
937
-13
-1% -$3.48K 0.17% 110
2022
Q1 		$248K Sell
950
-27
-3% -$6.41K 0.13% 133
2021
Q4 		$215K Buy
+977
New +$190K 0.11% 154

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Zullo Investment Group's VRTX Position: Q2 2026 in Review

Zullo Investment Group reduced its Vertex Pharmaceuticals (VRTX) stake by 0.15% in Q2 2026, selling an estimated $443 and leaving 660 shares worth $328K. The position accounts for 0.11% of the portfolio, ranked #121.

Zullo Investment Group first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $389K in Q1 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Zullo Investment Group held 660 shares of Vertex Pharmaceuticals worth $328K as of Q2 2026.
  • Zullo Investment Group sold 1 Vertex Pharmaceuticals share in Q2 2026, an estimated $443.
  • Vertex Pharmaceuticals made up 0.11% of Zullo Investment Group's portfolio in Q2 2026, its #121 holding.
  • Zullo Investment Group first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Zullo Investment Group's Vertex Pharmaceuticals position peaked at $389K in Q1 2025.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Zullo Investment Group's 13F filing for Q2 2026, filed 31 Jul 2026.